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Abstract
Background: Knee osteoarthritis (OA) is a global problem that causes significant pain and physical dysfunction,
substantially impacting on quality of life and imposing enormous cost to the healthcare system. Exercise is pivotal
to OA management, yet uptake by people with knee OA is inadequate. Limited access to appropriately skilled
health professionals, such as physiotherapists, for prescription of an exercise program and support with exercise is a
major barrier to optimal care. Internet-enabled video consultations permit widespread reach. However, services
offering video consultations with physiotherapists for musculoskeletal conditions are scant in Australia where there
is typically no Government or private health insurer funding for such services. The paucity of robust evidence
demonstrating video consultations with physiotherapists are clinically effective, safe and cost-effective for knee OA
is hampering implementation of, and willingness of healthcare policymakers to pay for, these services.
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Methods: This is an assessor- and participant-blinded, two-arm, pragmatic, comparative effectiveness non-inferiority
randomised controlled trial (RCT) conducted in Australia. We are recruiting 394 people from the community with
chronic knee pain consistent with a clinical diagnosis of knee OA. Participants are randomly allocated to receive
physiotherapy care via i) video-conferencing or; ii) face-to-face consultations. Participants are provided five
consultations (30–45 min each) with a physiotherapist over 3 months for prescription of a home-based
strengthening exercise program (to be conducted independently at home) and physical activity plan, as well as OA
education. Participants in both groups are provided with educational booklets and simple exercise equipment via
post. The co-primary outcomes are change in self-reported i) knee pain on walking; and ii) physical function, with a
primary end-point of 3 months and a secondary end-point of 9 months. Secondary outcomes include changes in
other clinical outcomes (health-related quality of life; therapeutic relationship; global ratings of change; satisfaction
with care; self-efficacy; physical activity levels), time and financial costs of attending consultations, healthcare usage
and convenience. Non-inferiority will be assessed using the per-protocol dataset.
Discussion: Findings will determine if video consultations with physiotherapists are non-inferior to traditional face-
to-face consultations for management of people with knee OA.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12619001240134. http://www.anzctr.org.au/
Trial/Registration/TrialReview.aspx?id=377672&isReview=true
Keywords: Osteoarthritis, OA, Knee, Telehealth, Telerehabilitation, Rehabilitation, Physiotherapy, Clinical trial, RCT,
Musculoskeletal, Pain, Exercise, Physical activity, Non-inferiority
Background
Arthritis and musculoskeletal conditions are an Australian
National Health Priority Area, and more prevalent in
Australia than any other, including cancer, diabetes and
obesity [1]. Osteoarthritis, particularly of the knee, is a
leading cause of pain and disability in Australia, and the
12th highest contributor to global disability [2]. Around
2.1 million Australians (1 in 11 people) have OA, with a
58% increase expected by 2032 due to population ageing
and rising obesity rates [1]. This reflects international data
showing that OA accounted for 303.1 million prevalent
cases across the globe in 2017 [3], with a 9.3% increase in
age-standardised point prevalence since 2010. Knee OA
can be extremely debilitating. Pain is a major symptom
and it may become persistent and more limiting over time.
Physical function can become increasingly impaired and
may impact substantially on quality of life and ability to
participate in social, leisure and occupational activities.
Health expenditure on OA in Australia in 2012 was $3.75
billion, with most costs related to conservative and surgi-
cal treatments, lost productivity and loss of quality of life.
With the aging and increasing obesity of the world’s popu-
lation, a large increase in demand for health services for
knee OA is expected in the future.
There is no cure for OA. Treatments to reduce symptoms
and delay or prevent joint replacement are critical. Clinical
guidelines for management of knee OA emphasise non-drug
non-surgical strategies [4–7] that focus on self-help and
patient-driven options rather than clinician-delivered passive
therapies. In particular, advice and information for self-
management, exercise and weight control (if required) are
core management, with drugs, injections and manual therapy
considered adjunctive to core treatments [4–7]. Exercise is
advised for all people with knee OA irrespective of age, OA
severity, pain, function and comorbidities [6]. The benefits of
exercise for knee OA on pain, physical function and quality
of life are well-established [8, 9]. Given that muscle weakness
is widespread in knee OA [10], muscle strengthening is an
important component of exercise programs for people with
the condition.
Knee OA is mostly managed in primary care settings,
with physiotherapists frequently involved in provision of
care. Physiotherapy is traditionally provided during face-to-
face consultations in the clinic. However, for many people,
access to physiotherapy is hampered by geographical isola-
tion and/or limited physiotherapy services. This is particu-
larly a problem in regional and remote areas where services
are often limited or non-existent. Face-to-face consultations
also pose an infection risk for both the physiotherapist and
the patient. This has been highlighted by the COVID-19
pandemic where many physiotherapy practices across the
globe have restricted or ceased face-to-face consultations
and instead shifted towards telehealth, in order to safeguard
the health of both patients and staff.
We conducted the first RCT evaluating efficacy of video
consultations with a physiotherapist for exercise manage-
ment of knee OA [11]. We recruited 148 older people
around Australia and compared video consultations (deliv-
ered by 8 different physiotherapists) combined with a self-
directed online pain coping skills program, versus online
education. Findings showed that the intervention signifi-
cantly improved knee pain and physical function by clinic-
ally meaningful amounts at 3months, and that benefits
were sustained at 9months. Furthermore, nested qualitative
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research showed that video consultations were acceptable to
both patients and physiotherapists [12]. Patient convenience,
flexibility, empowerment to self-manage and positive thera-
peutic relationships were emphasised by both patients and
physiotherapists. Patients were very satisfied with the care
they received and believed it was effective for them person-
ally. These findings reflect survey data in people with knee
OA [13] and in patients attending hospital-based physiother-
apy screening clinics [14], as well as RCT findings in patients
following joint replacement [15]. Collectively, research indi-
cates most patients are willing to engage in video consulta-
tions for chronic musculoskeletal conditions. However, there
is no research comparing the effectiveness of video-
conferencing with physiotherapists to face-to-face consulta-
tions for people with knee OA.
The primary aim of this RCT is to determine if video-
conferencing consultations are non-inferior to face-to-face
consultations with a physiotherapist for improving knee
pain on walking and/or physical function at 3months (pri-
mary time-point) and 9months (secondary time-point), in
people with knee OA. We hypothesise that video consulta-
tions are not inferior for improving knee pain on walking
and/or physical function compared to face-to-face care in
people with knee OA. Secondary aims are to compare the
clinical effectiveness (health-related quality of life, thera-
peutic relationship, global ratings of change, satisfaction
with care, self-efficacy, physical activity levels), cost-
effectiveness (participant-level travel time and travel-related
costs, health care usage) and convenience of video-
conferencing consultations to face-to-face consultations, as
well as explore potential moderators of treatment effect.
Methods
Study design
A multi-site, two-arm, parallel, pragmatic, comparative
effectiveness non-inferiority RCT is being conducted,
with a health economic analysis. This protocol has been
developed according to the SPIRIT statement [16]. The
RCT was prospectively registered with the Australian
and New Zealand Clinical Trials Registry (ACTR
N12619001240134). Findings of the trial will be reported
according to CONSORT guidelines for reporting of non-
inferiority trials [17] and non-pharmacological interven-
tions [18], and the Australia & New Zealand Musculo-
skeletal (ANZMUSC) Clinical Trial Network governance
and publication policies (https://anzmusc.org).
Participants
A total of 394 people with chronic knee pain, consistent
with a clinical diagnosis of knee OA, will be recruited. Par-
ticipants are recruited from the community (in geograph-
ical locations surrounding our trial physiotherapists) in
Victoria, Queensland, and New South Wales via commu-
nity advertisements, print/radio/social media, clinicians and
our volunteer database. Volunteers are initially screened by
an online form, then over the phone by the Trial Coordin-
ator. Volunteers uncomfortable with online screening can
instead call a telephone number and proceed directly to
phone screening. Participants are eligible for the study if
they meet the following inclusion criteria:
i. meet National Institute for Health and Care
Excellence [6] clinical criteria for OA;
i. age ≥ 45 years;
ii. report activity-related knee joint pain and;
iii. report no morning stiffness or morning knee
stiffness lasting ≤30 mins;
ii. report history of knee pain ≥3mths;
iii. report knee pain on most days of the past month;
iv. report an average pain score ≥ 4 on an 11-point
numeric rating scale during walking over the
previous week;
v. report difficulty walking and climbing stairs;
vi. access to a device with internet connection;
vii. willing and able to travel to the nearest trial
physiotherapist if required; and
viii.pass the Exercise and Sports Science Australia stage
1 pre-exercise screening questions [19].
Participants are excluded if they:
i. are unable to speak English;
ii. are on a waiting list/planning for knee/hip surgery
in next 12 months;
iii. have had previous arthroplasty on affected knee;
iv. report recent knee surgery (past 6 months);
v. are currently consulting/ed. a physiotherapist or doing
strengthening exercise for their knee (past 6months);
vi. report any inflammatory arthritis (e.g. rheumatoid
arthritis);
vii. report any neurological condition affecting lower
limbs; and/or
viii.report any unstable/uncontrolled cardiovascular
condition.
Anyone who i) reports a fall (past 12 months) or is
house-bound due to immobility; or ii) who fails the Ex-
ercise and Sports Science Australia stage 1 pre-exercise
screening questions is asked to obtain clearance from a
general practitioner to participate. In cases where an eli-
gible participant has bilateral knee symptoms, the most
symptomatic knee is considered the study knee.
Procedures overview
The flow of participants through the RCT is outlined in
Fig. 1. All potential participants receive oral and written
information about the purposes, potential risks and pro-
cesses involved in the study from the Trial Coordinator.
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Once participants pass the telephone screening process,
which involves a detailed verbal description of the pro-
ject, they are sent a Plain Language Statement and Con-
sent Form in the post or by email. Ethical approval has
been obtained from the University of Melbourne Human
Research Ethics Committee (HREC No. 1953585.1). All
participants provide written informed consent.
All outcomes are participant-reported. Participants
complete outcome assessments via electronic survey
(REDCap) or paper-based (returned via mail for the mi-
nority that may request this). In addition, all participants
record attendance at, and travel information about,
physiotherapy consultations using a log book which is
mailed back to research staff. As a reminder, research
staff contact any participant who has failed to submit a
survey and/or return a log book by the due date. Every
effort is being made to minimize loss of data, including
collection of primary outcome data over the telephone if
necessary.
Immediately upon receipt of the signed consent form and
completed baseline survey, a participant is randomized to
either video-conferencing or face-to-face consultations with
the trial physiotherapist of their choice (usually selected on
the basis of geographical location). Participants are pro-
vided five physiotherapy consultations over a 12-week
intervention period. Research staff book the first two con-
sultations on behalf of the participant with the physiothera-
pist’s clinic at mutually agreeable times. Thereafter, the
physiotherapist and participants arrange subsequent book-
ings together at the conclusion of each consultation.
Assessed for eligibility by 
online screen
Assessed for eligibility by 
telephone
Ineligible:
Fail inclusion criteria
Meet exclusion criteria
Refuse to participate
Baseline assessment (n=394)
Randomization 
stratified by physiotherapist
Ineligible:
Fail inclusion criteria
Meet exclusion criteria
Did not obtain GP clearance
No longer interested
Allocated to video 
consultations (n=197)
Allocated to face-to-face 
consultations (n=197)
Second assessment
(Primary time-point: 3 months)
Final assessment
(Secondary time-point: 9 months)
Per protocol analysis for non-inferiority
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Informed consent (n=394)
Hard-copy educational 
resources & exercise 
equipment
+
5 consultations with a 
physiotherapist via video 
conferencing
Hard-copy educational 
resources & exercise 
equipment
+
5 consultations with a 
physiotherapist face-to-face in 
clinic
Fig. 1 Flow of participants through the RCT
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Randomisation, blinding and allocation concealment
The randomisation schedule was prepared by a biostatis-
tician using permuted block sizes 6 to 12 and a random-
isation ratio of 1:1, stratified by trial physiotherapist.
Where physiotherapists practice at two different clinic
locations, randomisation is stratified by location within
the physiotherapist. The randomisation schedule is
stored on a password-protected website (REDCap) at the
University of Melbourne and maintained by a researcher
not involved in either participant recruitment or admin-
istration of primary/secondary outcome measures.
Group allocation is revealed by this same researcher
after baseline assessment has been completed.
Participants are blinded to group allocation by a
process of limited disclosure. Participants are informed
that physiotherapy services in the ‘real-world’ may be
provided in a variety of settings and models of delivery,
such as face-to-face care, telephone consultations, video-
conferencing, individual consultations, group classes,
community health services, rehabilitation services, pri-
vate practices and hospital settings and home visits.
They are informed that the purpose of the RCT is to
compare the effectiveness of two different models of
physiotherapy service. Although participants are in-
formed they will receive a series of consultations with a
physiotherapist (for education, strengthening exercise
and a physical activity plan), they are not told that
video-conferencing is being compared to face-face indi-
vidual consultations. Participants will not be informed
about the study hypotheses, or the model of care re-
ceived by the comparator group, until the study is com-
pleted, at which time they will also be provided a lay
summary of findings. As all outcomes are participant-
reported, and participants are blinded, this study is thus
also considered assessor-blinded. It is not possible to
blind physiotherapists as they are providing consulta-
tions to both trial arms (in order to ensure
physiotherapist-related factors such as personality, clin-
ical practice experience etc. are similar across groups
and cannot confound results). Statistical analyses will be
performed in a blinded manner.
Physiotherapy care
Physiotherapists
Fifteen practicing musculoskeletal physiotherapists in
private practice in Victoria and Queensland were re-
cruited via Australian Physiotherapy Association elec-
tronic communications channels, and our own clinical
networks. These physiotherapists deliver care to partici-
pants randomized to both trial arms. Eligibility criteria
for the physiotherapists to participate were:
– Current registration to practice as a physiotherapist;
– Have a receptionist at their clinical practice to
facilitate patient bookings and communication with
research staff;
– Have access to a desktop or laptop computer with
internet connection and suitable work-space for
private video consultations in their clinical rooms;
– Have an Australian Business Number;
– Have some previous experience and confidence
using video conferencing software (e.g. Skype,
Zoom, FaceTime);
– Willing to undertake trial training requirements; and
– Be willing and available to participate in the RCT
until end of 2021.
Physiotherapist training
Mandatory training was undertaken by all physiothera-
pists prior to being allocated a trial participant. Training
included:
 Bespoke self-directed e-learning modules (delivered
on the University of Melbourne Learning Manage-
ment System) about best-practice OA management,
telehealth (including delivery of care via Zoom video-
conferencing) and trial procedures, including the
structured physiotherapy treatment protocol. Physio-
therapists were told it would take approximately 5 h
to work through all e-learning modules, which they
were encouraged to complete at their own pace,
ideally over 4 weeks. The PEAK Training Program e-
learning modules have since been adapted, and re-
leased, for widespread use by clinicians outside of the
trial and access is available to users from all over the
globe via https://healthsciences.unimelb.edu.au/de-
partments/physiotherapy/about-us/chesm/news-and-
events/peak-training-program/);
 A mock initial consultation via video-conferencing
with a researcher acting as a patient, who provided
immediate feedback on performance;
 Four video consultations, with two pilot patients
with knee pain recruited by research staff (an initial
and a follow-up call for each patient), to practice
video consultation skills. Physiotherapists completed
a self-reflection exercise upon completion of the
pilot consultations (What went well? What didn’t go
so well? What would I do differently in future?). Re-
search staff conducted “spot” checks of consultation
recordings and provided feedback to individual phys-
iotherapists regarding performance after all pilot
consultations were complete;
 A video-conference with research staff to answer
any questions about trial procedures.
A hard copy of the trial protocol and procedures rele-
vant to the physiotherapist (incorporated into a single
Hinman et al. BMC Musculoskeletal Disorders          (2020) 21:522 Page 5 of 19
physiotherapist trial manual), as well as a copy of each
participant resource (see below) was also provided to
each physiotherapist.
Participant resources
Each trial participant is mailed a “welcome pack” of re-
sources to facilitate the management plans that physio-
therapists enact during the consultations. These
resources include:
– Four information booklets:
– “Preparing for your consultations” (information
about consultations, instructions on how to use
Zoom video-conferencing and activity tracker);
– “Osteoarthritis Information” (information about
knee OA, common management options, exercise
and physical activity, weight loss, pain management,
sleep and success stories);
– “Exercise Booklet” (strengthening exercise
instructions and photos, including information on
progressing exercises, managing flare-ups and deal-
ing with set-backs); and
– “Knee Plan and Log Book” (templates to record
details of management plans agreed upon at each
consultation and monitor progress with exercise and
physical activity goals).
– Four coloured elastic resistance bands (red, green,
blue, and black) for home-based strengthening exer-
cises; and
– A wearable activity tracker to facilitate physical
activity plans (Mi Band 4, Anhui Huami Information
Technology Co. Ltd., China) or pedometer (Omron
Healthcare, USA).
Consultations
In both trial arms, five consultations are offered with the
physiotherapist over 3 months (at approximately weeks
1, 2, 4, 7, 10), each lasting 30min except the first which
is 45 min. Participants are asked to complete an elec-
tronic pre-consultation survey prior to their first physio-
therapy consultation, which ascertains information about
their knee symptoms, previous treatments, activity levels
and personal goals. This survey is forwarded to the
physiotherapist prior to the first consultation.
Table 1 provides an overview of the main components
of each physiotherapy consultation. Consultations have
been informed by the Behaviour Change Wheel [20] (in-
cluding behaviour change techniques relevant for exer-
cise and physical activity [21, 22], Table 2) and based on
the research team’s prior research into exercise and
physical activity for knee OA [11, 23–27]. In summary,
physiotherapists aim to prescribe an individualised exer-
cise program comprising 5–6 strengthening exercises to
be performed at home three times/week, including two
quadriceps exercises, one hip/gluteal exercise, one ham-
strings/gluteal exercise, one calf exercise, and one other
as appropriate. Exercises are selected from an Exercise
Booklet containing 37 exercises in total (Table 3), many
with a range of potential variations to make them harder
or easier as required. The intensity for the strengthening
exercises is aimed at 5–7 out of ten (or, “hard to very
hard”) on the modified Borg Rating of Perceived Exer-
tion (RPE) scale [28] for strength training. Review and
modification of the strengthening program occurs at
each consultation. Progression is guided by American
College of Sports Medicine principles [29] via adjust-
ments to repetitions, direction, and speed of movements;
increasing resistance; and/or changing stance surface.
Physiotherapists also work with the patient to devise
an individualised physical activity plan, with the aim of
increasing physical activity to, or maintaining it at, rec-
ommended levels [30]. Participants use a wearable activ-
ity tracker to assist this and the physiotherapist and
participant devise individualised step goals that are
reviewed and modified (if required) at each consultation.
Participants are encouraged to use the “Knee Plan and
Log Book” for recording both their strengthening exer-
cise program and physical activity plan after each con-
sultation, and monitoring progress for discussion with
the physiotherapist at the next consultation. Education
about OA and its management occurs at all sessions, in-
cluding discussion about the role of exercise and phys-
ical activity, including barriers to adherence and
strategies for overcoming obstacles. Table 1 outlines the
different education topics at each consultation.
Participants are encouraged and advised how to inde-
pendently progress their exercise program and their phys-
ical activity plan between consultations, and beyond, once
the physiotherapist consultations have ceased. Participants
are encouraged to continue with their strengthening exer-
cises and physical activity plan after the physiotherapist
consultations have finished, up until the final outcome
measurements are collected at 9months. Participant use
of monitoring and tracking tools (“Knee Plan and Log
Book”; wearable activity tracker) is encouraged during the
consultations, and beyond, to facilitate ongoing adherence
to strengthening exercise and physical activity.
Mode of physiotherapy delivery
Face-to-face consultations – participants allocated to
this group attend all of their consultations with the
physiotherapist in the physiotherapist’s clinical practice
rooms. Participants travel to and from the clinic at their
own expense. Physiotherapists use their usual clinical
methods for teaching the strengthening exercise program
(ie demonstration, watching and correcting participant
technique). Consultations are audio-recorded using digital
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Table 1 Outline of the main components of each of the five consultations with the physiotherapist
Initial consultation (45
mins)- WEEK 1
Consultation 2 (30 mins)-
WEEK 2
Consultation 3 (30
mins)- WEEK 4
Consultation 4 (30
mins)- WEEK 7
Consultation 5 (30 mins)-
WEEK 10
Assessment 15 mins 5 mins 5 mins 5 mins 5 mins
Introduction and setting
expectations
Checking in … . Checking in … . Checking in … . Checking in … .
Review pre-consultation sur-
vey- choose questions for
future reassessment.
- changes in knee pain - changes in knee
pain
- changes in knee
pain
- changes in knee pain
- how they have managed
with strengthening
exercises
- how they have
managed with
overall program
- how they have
managed with
overall program
- how they have managed
with overall program
Subjective information as
relevant.
- adverse events? - adverse events? - adverse events? - adverse events?
Functional observation:
walking, squatting, sit to
stand, single leg standing
balance, anything else as
relevant.
- comments/questions
arising from discussions
last time.
- comments/
questions arising
from discussions
last time.
- comments/
questions arising
from discussions
last time.
- comments/question s
arising from discussions
last time.
Reassess questions
from pre-
consultation
survey.
Reassess questions from pre-
consultation survey.
Re-assess sit to
stand and any
other functional
tasks as required.
Re-assess sit to stand and
any other functional tasks as
required.
Check progress with goals.
Education 10 mins
Understanding OA.
Benefits of exercise/physical
activity.
Strengthening
exercises
15 mins 10 mins 10–15 min 10–15 min 15 mins
Choose a program of 3
exercises from booklet (1
quadriceps; 1 hip/gluteal; 1
hamstrings/gluteal)
Review progress. Review progress. Review progress. Review progress.
Check adherence in Log
Book.
Check adherence
in Log Book.
Check adherence
in Log Book.
Check adherence in Log
Book.
- Congratulate adherence. - Congratulate
adherence.
- Congratulate
adherence.
- Congratulate adherence.
Prescribe variation (if
necessary) and dosage.
- Discuss reasons for non-
adherence & troubleshoot.
- Discuss reasons
for non-
adherence &
troubleshoot.
- Discuss reasons
for non-
adherence &
troubleshoot.
- Discuss reasons for non-
adherence & troubleshoot.
Watch patient perform one
set of each exercise &
ensure they are working at
hard to very hard level.
Review current exercises &
modify/progress as required
& add 2–3 more to program
(max 6 in total; 2
quadriceps; 1 hip/gluteal; 1
hamstrings/gluteal; 1 calf; 1
optional extra).
Review current
exercises &
modify/progress
as required.
Review current
exercises &
modify/progress
as required.
Review current exercises &
modify/progress as required.
Discuss exercising with
pain/flare-ups.
Watch patient
perform one set of
any new exercises
& ensure they are
working hard to
very hard.
Watch patient
perform one set of
any new exercises
& ensure they are
working hard to
very hard.
Watch patient perform one
set of any new exercises &
ensure they are working
hard to very hard.Instruct use of Log Book.
Check patient knows how to
change/progress their
program over the next 6
months.
Watch patient perform one
set of each new exercise &
ensure they are working
hard to very hard).
Advise patient to continue
exercise program for next 6
months.
Education 5 mins
Physical activity.
Activity pacing.
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audio recorders and uploaded by the physiotherapist to a
secure password-protected cloud-based system.
Video consultations - participants allocated to this
group attend all of their consultations using the video-
conferencing facility of Zoom (Zoom Video Communi-
cations, Inc., USA), a commercial cloud-based system
accessible from any internet-connected computer, laptop
or mobile device. Physiotherapists consult from their clinic
using a lap-top or desk-top computer, whilst participants
are based at their home (or elsewhere if preferred). Instruc-
tions for accessing and downloading Zoom are provided to
participants and participants are encouraged to independ-
ently set themselves up in readiness for their first consult-
ation. Physiotherapists are given access to a bespoke
website containing a video library of all exercises contained
within the “Exercise Booklet” so that they can provide real-
time demonstration of exercises to participants during
video-conferencing, using the share-screen feature of
Zoom. Participants do not have access to the online video
library outside of the consultations. Video-conferencing
consultations are video-recorded via Zoom and files are
stored on a secure password-protected cloud-based system.
Treatment fidelity
Bespoke semi-structured consultation notes (paper-based
or electronic according to physiotherapist preference) will
be recorded by the physiotherapist for each consultation
and returned to research staff at the completion of the
participant’s series of consultations. Notes will be scruti-
nised by research staff for physiotherapist adherence to
trial protocols. Fidelity will be recorded as the number
and proportion of i) strengthening exercise programs pre-
scribed by the second consultation; ii) physical activity
plans prescribed by the second consultation; iii) follow-up
Table 1 Outline of the main components of each of the five consultations with the physiotherapist (Continued)
Initial consultation (45
mins)- WEEK 1
Consultation 2 (30 mins)-
WEEK 2
Consultation 3 (30
mins)- WEEK 4
Consultation 4 (30
mins)- WEEK 7
Consultation 5 (30 mins)-
WEEK 10
Physical
activity
5 mins 10 mins 5–10 min 5–10 min 5 mins
Check patient has activity
tracker set up and can use
it.
Review daily step count
recorded in Log Book.
Review daily step
count recorded in
Log Book.
Review daily step
count recorded in
Log Book.
Review daily step count
recorded in Log Book.
Instruct patient to wear
activity tracker every day for
next week and record daily
steps as a baseline for
developing a daily step goal
at the next visit.
Set daily step goal (may be
maintain or increase from
baseline).
Review progress
with physical
activity plan.
Review progress
with physical
activity plan.
Review progress with
physical activity plan.
- Congratulate adherence.
Agree on physical activity
plan to achieve steps and/or
increase/maintain intensity
of activity.
- Congratulate
adherence.
- Congratulate
adherence.
- Discuss reasons for non-
adherence & troubleshoot.
- Discuss reasons
for non-
adherence &
troubleshoot.
- Discuss reasons
for non-
adherence &
troubleshoot.
Set an ongoing physical
activity plan that patient can
manage in daily life (may/
may not include step goals
& use of activity tracker
based on patient choice).Instruct use of Log Book. Ask patient to identify
potential barriers & plan
strategies for overcoming
them.
Set daily step goal
for coming weeks
(may be to
maintain or
increase from
previous weeks).
Agree on physical
activity plan to
achieve step goal
and/or increase/
maintain intensity
of activity.
Set daily step goal
for coming weeks
(may be to
maintain or
increase from
previous weeks).
Agree on physical
activity plan to
achieve step goal
and/or increase/
maintain intensity
of activity.
Check patient knows how to
change/progress their
program as required.
Advise patient to continue
physical activity for next 6
months.
Education 5 mins 5 mins 5 mins
Understanding &
managing your
pain.
Weight loss for OA
(relevant for all
patients, even
those of healthy
body weight)
Dealing with lapses & set-
backs.
Encourage ongoing use of
Log Book and activity
tracker where possible.
Participant
‘homework’
Pre-reading: Pre-reading: Pre-reading: Pre-reading: Encourage reading of:
Physical activity. Barriers to exercise and
physical activity.
Weight loss for
OA- if appropriate
for the individual.
Modifying your
exercise program.
Success stories.
Activity pacing. Understanding & managing
pain.
Dealing with
lapses & set-backs.
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Table 2 Main behaviour change techniques that are incorporated into the intervention components for both trial arms
Behaviours:
- Undertake strengthening exercise program
- Undertake negotiated physical activity plan
Behaviour change technique Written
information
Physiotherapist
discussion
Other
Consequences of behaviour
Explanation of benefits of exercise & physical activity. ✓ OA Info
booklet
✓ Consult #1
Explanation that exercise & physical activity will not make joint structural
damage worse.
✓ OA Info
booklet
✓ Consult #1
Goal setting & action planning
Use of a plan stating how often to exercise & which exercises to do (including
dosage).
✓ Knee plan &
log book
✓ Consults #1–5
Development of specific goals related to patient’s knee problems. ✓ Consult #1 & 5 ✓ Pre-consultation
survey
Development of specific physical activity & step goals. ✓ Knee plan &
log book
✓ Consults #2–5
Barrier identification/planning
Information & discussion about barriers to exercise & physical activity
adherence, including problem-solving.
✓ OA Info
booklet
✓ Consults #1–5
✓ Knee plan &
log book
✓ Exercise
booklet
Behavioural grading & instruction
Strengthening exercises are graded in number, intensity and/or difficulty to get
progressively harder over time.
✓ Knee plan &
log book
✓ Consults #1–5 ✓ Four graded
resistance bands
✓ Exercise
booklet
Physical activity is graded in duration, intensity and/or frequency to get
progressively harder over time.
✓ OA Info
booklet
✓ Consults #1–5
✓ Knee plan &
log book
Instruction in where, when and how to perform physical activity ✓ Knee plan &
log book
✓ Consults #2–5
Instruction in where, when and how to perform strengthening exercises ✓ Knee plan &
log book
✓ Consults #1–5 ✓ Four graded
resistance bands
✓ Exercise
booklet
Demonstration of how to perform strengthening exercises ✓ Consults #1–5 ✓ Online video library
Encouragement to join group exercise classes. ✓ OA Info
booklet
✓ Consults #2–5
Encouraged to involve partner or family to join in with exercising & physical
activity.
✓ OA Info
booklet
✓ Consults #2–5
Self-monitoring & feedback
Encouraged to self-monitor exercise & physical activity ✓ Knee plan &
log book
✓ Consults #1–5 ✓ Activity monitor
Physiotherapist review of & and feedback on exercise & physical activity
recorded
✓ Knee plan &
log book
✓ Consults #2–5 ✓ Activity monitor
Relapse prevention
Instruction on how to modify exercise & physical activity during flare-ups ✓ Exercise
booklet
✓ Consults #1–5
Planning for set-backs in physical activity & how to overcome them ✓ Consult #2
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consultations that reviewed strengthening programs; iv)
follow-up consultations that reviewed physical activity
plans; v) consultations where the RPE for the strength
program was between 5 and 7; vi) all consultations that in-
cluded education. The mean (SD) RPE for each partici-
pant’s strengthening exercise program will be determined
over their consultations, as recorded in the treatment
notes.
Outcome measures
Table 4 summarises the schedule of enrolment, interven-
tions and outcome measures for this RCT according to
SPIRIT recommendations [16].
Primary outcomes
There is no single common symptom that drives all
people with knee OA to seek care from a physiotherap-
ist. However, the two predominant reasons are for relief
of knee pain and/or assistance with physical dysfunction
[31, 32]. Furthermore, assessing both of these symptoms
as quality indicators for the primary care of OA, is advo-
cated [33, 34]. Thus we have chosen co-primary out-
comes of change in i) pain; and ii) physical function,
both of which are also specifically advocated for use in
clinical trials in people with knee OA [35, 36]. The pri-
mary end-point is 3 months and the secondary end-
point is 9 months. Change scores at each end-point are
calculated using data measured at baseline, 3 months
and 9months using the following tools:
Severity of knee pain during walking
Average pain on walking in the last week is measured
using an 11-point NRS with terminal descriptors ‘no
pain’ (score = 0) and ‘worst pain possible’ (score = 10)
from baseline, 3, and 9 months. This scale has demon-
strated reliability in OA [37].
Physical function subscale of the Western Ontario and
McMaster universities osteoarthritis index (WOMAC)
The Western Ontario and McMaster Universities
(WOMAC) Osteoarthritis Index (Likert version 3.1) is used
to assess limitations with physical functioning [38]. The
self-reported tool is a disease-specific instrument which has
established validity, reliability and responsiveness in an ex-
tensive range of OA studies [39]. The subscale contains 17
questions on knee function over the past week, with Likert
response options from ‘no dysfunction’ (score = 0) to ‘ex-
treme dysfunction’ (score = 4). Total score ranges from 0 to
68, with higher scores indicating worse function.
Secondary outcomes
For quality of life, physical activity and self-efficacy,
change scores are calculated using data measured at
baseline, 3 months and 9months. Other secondary out-
comes are measured at time-points as indicated below:
Health-related quality of life
Health-related quality of life is evaluated using the As-
sessment of Quality of Life (AQoL) (version AQoL-6D)
[40]. The AQoL-6D contains 20 items that assess
Table 2 Main behaviour change techniques that are incorporated into the intervention components for both trial arms (Continued)
Dealing with lapses & set-backs with exercise & physical activity; use of con-
structive self-talk
✓ Exercise
booklet
✓ Consult #5
Pain & emotional control
Encouragement to use activity pacing & pain coping activities (eg relaxation,
pleasant imagery, mindfulness)
✓ OA Info
booklet
✓ Consults #2 & 3
Tips for healthy sleep ✓ OA Info
booklet
✓ Consult #3
Prompts
Encouraged to use reminders to exercise. ✓ OA Info
booklet
Rewards
Patient encouraged to use self-rewards for achieving exercise & physical activity
goals
✓ OA Info
booklet
✓ Consults #2–5
Physiotherapist congratulates adherence to exercise & physical activity ✓ Consults #2–5
Social comparison
Encourage reading of patient success stories ✓ OA Info
booklet
✓ Consult #5
Review
Review of behavioural goals (exercise & physical activity) at follow-up. ✓ Consults #2–5
Review of outcomes (pain and function) at follow-up. ✓ Consults #2–5
Review, supervision and correction of strengthening exercise technique. ✓ Consults #1–5
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Table 3 Strengthening exercise protocol, with progressions (where applicable)
Maximum of 6 exercises at any one time, performed three times/week
2 quadriceps strengthening exercises
1 hip abduction/gluteal strengthening exercise
1 hamstring/gluteal strengthening exercise
1 calf strengthening exercise
1 other exercise as appropriate
1. Quads strengthening
Knee
extension
Non
weight-
bearing
Q1. Seated knee extension Progression: Increase resistance with elastic band – red through
to black
Non
weight-
bearing
Q2. Inner range quads over roll
Sit-to-stand Weight-
bearing
Q3. Sit to stand without using hands Progression: lower chair height, hover above the seat without
touching down, add resistance band around knees and push
outwards while performing sit to stand
Weight-
bearing
Q4. Asymmetrical chair stands (with more weight
on arthritis leg)
Steps Weight-
bearing
Q5. Step-ups Progression: Increase step height
Weight-
bearing
Q6. Forward touch-downs from a step Progression: Increase step height, don’t touch floor
Weight-
bearing
Q7. Step-ups with weight Progression: Increase step height, increase weight
Weight-
bearing
Q8. Forward touch-downs with weight Progression: Increase step height, increase weight
Wall squats Weight-
bearing
Q9. Partial wall squats Progression: Halfway hold in bent-knee position, increase the
amount of body weight taken through the arthritis knee.
Weight-
bearing
Q10. Split leg wall squats
Controlled
squats
Weight-
bearing
Q11. Controlled squats (with back of chair
support)
Controlled
knee flexion/
extension
Weight-
bearing
Q12. Controlled knee flexion/extension with
forwards/backwards sliding of opposite leg
Weight-
bearing
Q13. Controlled knee flexion/extension with
forwards/backwards sliding of opposite leg with
elastic band
Progression: Increase resistance by changing elastic band colour
– red through to black
Weight-
bearing
Q16. Controlled knee flexion/extension with
sideways sliding of opposite leg
Weight-
bearing
Q17. Controlled knee flexion/extension with
elastic band and sideways sliding of opposite leg
Progression: Increase resistance by changing elastic band colour
– red through to black
Step to single
leg balance
Weight-
bearing
Q14. Step to standing balance on semi-flexed
knee
Weight-
bearing
Q15. Step to standing balance on semi-flexed
knee with arm movements
2. Hip abductor/gluteal strengthening
Standing hip
abduction
Non
weight-
bearing
HA1. Side leg raises in standing with elastic band. Progression: Increase resistance by changing elastic band colour
– red through to black, add halfway hold
Weight-
bearing
HA3. Wall push with opposite leg, standing on
straight arthritis leg
Progression: Hold weight in hand, increase the hold time
Weight-
bearing
HA4. Wall push with opposite leg, standing on
arthritis leg with deeper knee bending
Side stepping Weight- HA2. Crab walking with elastic band Progression: Increase resistance by changing elastic band colour
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independent living, mental health, relationships, pain,
coping and senses. Total scores range from − 0.04 to
1.00, with higher scores indicating better quality of life.
Physical activity levels
Physical activity over the previous week is assessed using
self-report tool, the Physical Activity Scale for the Eld-
erly (PASE) [41]. Total PASE scores range from 0 to
over 400, with higher scores indicating greater physical
activity.
Self-efficacy
Using the 8-item Arthritis Self Efficacy Scale [42], partic-
ipants rate how certain they are that they can do 8 tasks
using response options ranging from 1 (very uncertain)
to 10 (very certain). Total scores are an average of the 8
items with a range from 1 to 10; higher scores indicate
higher self-efficacy.
Participant-perceived global change
Participants rate their overall global i) change in pain, ii)
change in physical function, and iii) change in physical
Table 3 Strengthening exercise protocol, with progressions (where applicable) (Continued)
bearing – red through to black
3. Hamstring/gluteal strengthening
Supine
bridging
Weight-
bearing
HG1. Bridge with hold
Weight-
bearing
HG2. Split leg bridge with hold
Weight-
bearing
HG3. Single-leg bridge with hold
Standing knee
flexion
Non
weight-
bearing
HG4. Hamstring curls standing over bench
Non
weight-
bearing
HG5. Hamstring curls standing over bench with
elastic band
Progression: Increase resistance by changing elastic band colour
– red through to black
Seated knee
flexion
Non
weight-
bearing
HG6. Seated knee flexion with elastic band Progression: Increase resistance by changing elastic band colour
– red through to black
Standing hip
extension
Non
weight-
bearing
HG7. Hip extension with knee bent (90°) standing
over a bench
Non
weight-
bearing
HG8. Hip extension with knee straight standing
over a bench
Non
weight-
bearing
HG9. Hip extension with knee straight with
elastic band standing over a bench
Progression: Increase resistance by changing elastic band colour
– red through to black
4. Calf strengthening
Standing
plantar-flexion
Weight-
bearing
C1. Double leg calf raises
Weight-
bearing
C2. Single leg calf raises
Weight-
bearing
C3. Double leg calf raises over edge of step
Weight-
bearing
C4. Single leg calf raises over edge of step
5. Balance (if appropriate)
Tandem
stance
Weight-
bearing
B1. Maintain balance in tandem stance Progression: remove hand support (if required), slowly raise arms
in the air, eyes closed
Natural stance Weight-
bearing
B2. Maintain balance whilst tapping opposite foot
forwards & backwards
Single leg
stance
Weight-
bearing
B3. Maintain balance in single leg stance Progression: Increase hold time up, slowly raise arms up and
down, eyes closed
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Table 4 Schedule of enrolment, interventions and assessments
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activity at 3- and 9-months using separate 7-point Likert
scales with terminal descriptors of ‘much worse’ to
‘much better’ [43]. For each scale, participants that indi-
cate they are ‘moderately better’ or ‘much better’ are
classified as ‘improved’ and all others as ‘not improved’.
Satisfaction with the physiotherapy consultations
Participants rate their satisfaction with the physiotherapy
consultations at 3- and 9-months using a 7-point Likert
scale with terminal descriptors of ‘extremely unsatisfied’
to ‘extremely satisfied’. Participants who report being
‘moderately satisfied’ or ‘extremely satisfied’ are classified
as ‘satisfied’ and all others as ‘not satisfied’.
Therapeutic alliance
The Working Alliance Inventory Short Form [44] is
scored separately by both the participant (at 3-months)
and the physiotherapist (after the 5th consultation or on
the day the 5th consultation was due to be scheduled for
participants who cancel/do not attend). Overall scores
range from 12 to 84, with higher scores indicating a
stronger therapeutic alliance.
Convenience
Participants rate the convenience of their physiotherapy
consultations at 3 months using an 11-point NRS with
terminal descriptors of ‘extremely inconvenient’ (score =
0) and ‘extremely convenient’ (score = 10).
Attendance at consultations
Attendance at each consultation is recorded by physio-
therapists in treatment notes, and by participants in an
“Appointment Log Book”. The number of consultations
attended, number of consultations cancelled/rescheduled,
and number of consultations that were a “failed to attend”
are reported throughout the 3-month intervention period.
Adherence with strengthening exercise program
At the 3-month and 9-month follow-up assessments,
participants rate their adherence with their prescribed
strengthening exercise program (“I have been doing my
exercises exactly as I was asked to by my PEAK trial
physiotherapist (number of sessions, exercises and repe-
titions)”) using an 11-point NRS (with terminal descrip-
tors of ‘strongly disagree’ (score = 0) and ‘strongly agree’
(score = 10)). At each time-point, participants also self-
report the number of strengthening exercise sessions
performed over the previous week.
Adherence with physical activity plan
At the 3-month and 9-month follow-up assessments,
participants rate their adherence with their physical ac-
tivity plan (“I followed the physical activity plan that my
PEAK trial physiotherapist helped me to develop”) using
an 11-point NRS (with terminal descriptors of ‘strongly
disagree’ (score = 0) and ‘strongly agree’ (score = 10)).
Co-interventions
Participants self-report any co-intervention use (medica-
tions for knee pain and any other treatments for knee
OA) at baseline, 3, 6 and 9-months as part of the
custom-developed survey collecting health service usage
data (see below).
Adverse events
Participants who experience any adverse outcomes are
instructed to discuss these with their physiotherapist,
who institutes appropriate advice and/or changes to the
strengthening exercise program and/or physical activity
plan. Any risks to participants are likely to be minor and
transient. In this trial, adverse events are defined as any
problem experienced in the study knee or elsewhere in
the body deemed by the participant to be a result of the
exercises, physical activity plans and/or advice given by
the physiotherapist AND at least one of i) that caused
increased pain and/or interfered with function for 2 days
or more, and/or ii) resulted in the participant seeking
treatment from a health professional. Adverse events are
ascertained by survey questions to participants at 3 and
9months. The number and type of events are reported.
Cost-effectiveness outcomes
Health service usage Participants retrospectively recall
their health service usage for their knee pain and/or as a
result of trial participation over 3-month intervals. Par-
ticipants complete a custom survey to indicate the fre-
quency of visits to health care providers for their knee
pain, use of prescription and over the counter medica-
tion, injections, hospitalisation and investigative proce-
dures at baseline, 3, 6 and 9months.
Participant time Participants record their total time
spent per consultation (including travelling to/from,
waiting and consultation time) in an Appointment Log
Book. Mean time for consultations is reported.
Physiotherapist time Physiotherapists record their total
time spent per consultation (excluding note-taking and
appointment scheduling). Mean time for consultations is
reported.
Participant travel Distance travelled to attend consulta-
tions, along with mode of transport (including vehicle
descriptions and need for another person to accompany
(if applicable)), is recorded by participants in an Ap-
pointment Log Book. Mean distance travelled, mode of
transport and need for another person is reported.
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Descriptive measures A range of participant self-
reported descriptive measures are recorded at baseline
including recruitment source; data collection mode;
height; body mass; body mass index; age; gender; dur-
ation of symptoms; geographical residential location;
education level; current employment status; problems
(pain, aching, discomfort or stiffness) in other joints; co-
morbidities (via the Self-Administered Comorbidity
Questionnaire [45]); expectation of treatment outcome
(rated on a 5-point ordinal scale with anchors of “no ef-
fect at all” to “complete recovery”); confidence using
technology in day to day life; frequency of use of a range
of technologies; beliefs about different models of physio-
therapy care delivery and previous experience with dif-
ferent models of physiotherapy care delivery.
Sample size calculations
Sample size is based on detecting non-inferiority of video
consultations relative to face-to-face at 3months after ran-
domisation. For change in NRS pain, a non-inferiority mar-
gin (NIM) of 0.95 units was chosen as this is less than the
lowest of the range (1.0–2.0 units) [46, 47] reported as the
minimum clinically important difference (MCID) by people
with chronic pain, and less than the MCID of 1.75 units (ex-
trapolated from a 100mm visual analogue scale (VAS)) [48]
for OA by clinician consensus. For change in WOMAC sub-
scales, a NIM of 8mm on VAS versions of WOMAC (score
0–100) is used in drug non-inferiority RCTs [49], as it is less
than the MCIDs of 9.1–9.3mm [50, 51]. We are using the
Likert version of WOMAC (scored 0–68) for function, thus
our NIM for change in function is 5.44 units (extrapolated
from 8mm). Assuming standard deviations (SD) of changes
from baseline of 2.8 and 15 units for pain and function re-
spectively and correlations of 0.3 between baseline and
follow-up [11, 26], 15% loss to follow-up, 90% power, and a
one-sided 2.5% significance level, we need 197 people/arm
for change in pain and 172/arm for change in function, a
total of 394 people.
Statistical analysis plan
The a priori statistical analysis plan is described below.
Any future amendments to this statistical plan will be doc-
umented, dated and explained in an electronic log kept by
the research team, which will be made available upon re-
quest. A biostatistician will perform data analyses.
Consistent with OARSI guidelines [52], non-inferiority
will be assessed using the per-protocol dataset (including
only those randomized participants who attended ≥3
consultations). Between-group differences in mean
change in pain and function (baseline minus follow-up)
will be compared using linear regression modelling ad-
justed for baseline and the stratifying variable of physio-
therapist. If a physiotherapist treats participants at two
locations, two separate terms for that physiotherapist,
corresponding to each location, will be included. Non-
inferiority will be demonstrated if the lower bound of
the two-sided 95% CI for between-group difference
(video-conferencing minus face-to-face) is above − 0.95
for change in pain and/or − 5.44 for change in function,
at 3 months. 95% CIs correspond to testing the null hy-
pothesis of non-inferiority at a one-sided significance
level of 2.5%. Due to difficulties with their interpretation,
p-values associated with non-inferiority hypotheses are
not commonly reported and will not be reported here
[53]. Multiple imputation will be used to impute missing
data, and an intention-to-treat analysis (including all
participants in their randomised groups) will be con-
ducted to help assess robustness of conclusions (sensitiv-
ity analysis). Given that participants with knee OA seek
physiotherapy care for different reasons, we will inter-
pret and report findings transparently and separately for
each co-primary outcome. For example, if we demon-
strate non-inferiority of video consultations with respect
to function but not pain, we will conclude that video
consultations are non-inferior to face-to-face care for
improving function but are inferior for pain relief in
people with knee OA. Patients seeking care, and physio-
therapists delivering care, will then be fully informed
about benefits, and limitations, of video consultations
compared to face-to-face care with respect to the differ-
ent co-primary outcomes. If non-inferiority of a co-
primary outcome is demonstrated, superiority of the
outcome will then be assessed using the intention-to-
treat dataset and declared if the lower bound of the two-
sided 95% CI for between-group difference exceeds zero.
Secondary outcomes will be assessed using data from all
participants (i.e. the intention-to-treat sample) and confi-
dence intervals will be interpreted using the superiority
framework since we have not pre-defined any NIMs for
these outcomes. Linear regression models will be fit to
compare continuous outcomes; proportional odds models
to compare improvement based on global change; and
Poisson or negative binomial regression models to com-
pare count outcomes as appropriate. Assumptions will be
assessed using standard diagnostic plots and methods.
Since these are all secondary analyses, p-values for these
assessments will not be adjusted for multiple comparisons
[54, 55]. In addition, the outcomes of participant time,
physiotherapist time and travel time will be compared be-
tween treatment groups using the superiority framework,
similarly to other secondary outcomes.
Irrespective of the outcomes of the non-inferiority
analysis, we will conduct exploratory analyses to evaluate
moderation of the effect of video-conferencing versus
face-to-face consultations on primary outcomes by pre-
specified potential moderators, i) experience with online
video platforms; ii) geographical residence; iii) beliefs
about physiotherapy care delivery; and iv) confidence
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using technology. This will be assessed by including ap-
propriate interaction terms between the moderators and
the intervention term, where the superiority framework
will be applied for interpreting results. The a priori hy-
potheses to be tested are:
i. Participants who are less frequent users of video platforms
will have less improvement in primary outcomes with
video consultations (relative to face-to-face), compared to
participants who are more frequent users.
ii. Participants who don’t live in major city areas will
report greater ease of access, and reduced
participant-level time and financial costs (secondary
outcomes) with video consultations (relative to
face-to-face), compared to participants who live in
major cities.
iii. Participants who believe that video consultations
are less effective for managing musculoskeletal
problems will report less improvement in primary
outcomes with video consultations (relative to face-
to-face), compared to those who believe video con-
sultations are more effective.
iv. Participants who are less confident with using
technology will report less improvement in primary
outcomes with video consultations (relative to face-
to-face), compared to participants who are more
confident.
Economic evaluation
A health economist will oversee assessment of incre-
mental direct and indirect costs of video consultations
compared to face-to-face. Primary evaluation will be
between-group difference in knee-related health care
costs and quality-adjusted life years (QALYs) using gen-
eralised linear models to adjust for baseline. Non-
inferiority in QALYs will be demonstrated if the lower
bound of the two-sided 95% CI for between-group dif-
ference of the AQoL-6D is above − 0.08 (half a SD). If
one type of consultation is superior but costs more,
QALYs will be calculated using area under the curve
over 9 months. The incremental cost per QALY as the
ratio of difference in mean cost to difference in mean
QALYs, and net benefits as the difference in QALYs
times the social value of a QALY minus the difference in
cost, will then be calculated. If non-inferiority of QALYs
is demonstrated, then inferiority in terms of cost (and
net benefits) will then be assessed if the lower bound of
the two-sided 95% CI for between-group difference ex-
ceeds zero. In a secondary analysis, the cost of patient
time will be included as an additional cost component.
Patient and public involvement
No patients were involved in setting the research ques-
tion. Patients with knee OA were involved in i) review of
the plain language statement and consent form, particu-
larly the text related to limited disclosure; ii) review and
completion of the electronic outcome measurement sur-
vey; iii) testing the participant instructions for, and use
of, the wearable activity tracker; iv) testing participant
instructions for, and use of, Zoom for video-
conferencing; v) review of other participant resources
(Osteoarthritis Information, Exercise Booklet) and the
Appointment Log Book used in data collection; vi) creation
of telehealth training videos for the physiotherapist e-
learning modules, and exercise videos/photographs for the
website/Exercise Booklet, as patient actors; and vii) review
of study logo. Patients provided feedback to the research
team about information content, presentation and readabil-
ity, as well as time taken to complete the outcome measure-
ment survey. Patients with knee OA also participated in
pilot “practice consultations” with the trial physiotherapists
as part of the physiotherapist’s training procedures.
Representatives of the national physiotherapy profes-
sional body (Australian Physiotherapy Association) were
involved in designing the trial (including selecting out-
come measures) and obtaining funding. The Australian
Physiotherapy Association assisted in physiotherapist re-
cruitment by advertising for physiotherapists to partici-
pate in the trial via member electronic communications.
Physiotherapists (not otherwise involved in the trial) i)
reviewed the exercises contained within the “Exercise
Booklet” and suggested the addition of three new bal-
ance exercises; ii) reviewed and provided feedback on
the physiotherapist “Zoom Troubleshooting” resource
embedded within the e-learning modules and physio-
therapist trial manual; and iii) performed as actors/
models in the creation of telehealth training videos for
the physiotherapist e-learning modules.
The trial protocol underwent independent review by
the ANZMUSC Clinical Trials Network, which included
a written submission and a verbal presentation in an
open forum to ANZMUSC members, review by two
members from each of the Scientific Advisory Commit-
tee and the Consumer Advisory Group. The trial was
endorsed by ANZMUSC on 25/07/2019, indicating its
high priority and quality, importance to consumers/pa-
tients, clinicians and policy makers, and its potential to
improve patient outcomes.
Timelines
Ethics approval was obtained from the University of Mel-
bourne Human Research Ethics Committee in May 2019.
Physiotherapists were recruited and underwent training
(on a rolling basis) between October 2019 and March
2020. Participant recruitment commenced in November
2019 and is anticipated to be completed in August 2021
but may be extended depending on the impact of the
COVID-19 pandemic on recruitment rates. The trial is
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currently anticipated to be completed by May 2022, when
all participants are currently anticipated to have com-
pleted 9-month follow-up.
Discussion
Although our prior research [11] showed that video con-
sultations with a physiotherapist (combined with pain
coping skills training) are efficacious compared to online
education, it remains unclear how effective video consul-
tations are compared to traditional face-face physiother-
apy care. Physiotherapy is viewed by the public and the
wider healthcare community as a profession associated
with “hands-on” and “physical” treatments. Foster and
Delitto [56] have described how perceptions of physiother-
apy professional culture form, and how patient preferences
and expectations drive clinician practice and beliefs. Pa-
tients often expect to receive manual therapy treatments
when consulting a physiotherapist, and physiotherapists
themselves have traditionally been trained in a biomedical
approach emphasising “hands-on” assessment and treat-
ment techniques, despite the limited evidence for these ap-
proaches in many chronic musculoskeletal conditions,
including knee OA. Robust high-quality non-inferiority
RCTs are required to provide evidence that video consulta-
tions are non-inferior to face-to-face care in order to drive
changes in service delivery models and funding policy.
Our trial is robust and will provide high-quality evi-
dence about the effectiveness of video-conferencing
compared to face-to-face physiotherapy care. Most prag-
matic RCTs are superiority trials, which assess if a new
approach is more effective than another standard inter-
vention. In contrast, non-inferiority trials assess whether
the effects of the new approach are within a predefined
clinically acceptable margin of the effects of the standard
approach [57]. Non-inferiority RCTs typically require
larger sample sizes than superiority trials because the
NIM is typically smaller than the treatment effect that a
similar superiority trial comparing the standard treat-
ment to a comparison/placebo would be powered to de-
tect. The study power of non-inferiority trials is usually
chosen to be high (usually 90%) to minimise the risk that
a non-inferior treatment is missed due to chance [57].
Within our RCT, we plan to conduct a linked discrete
choice experiment exploring patient preferences for re-
ceiving physiotherapy care, as well as qualitative evalua-
tions of i) physiotherapist experiences with training for
the trial; and ii) physiotherapist and patient experiences
with, and attitudes towards, video consultations. These
linked studies will be reported separately from the main
trial findings.
A systematic review and meta-analysis evaluated the
effectiveness of treatment delivered via telerehabilitation
for musculoskeletal conditions [58]. Of the 14 trials in-
cluded, only three in people with OA were identified
(one of these with a sample of mixed arthritic diagnoses)
and none investigated video consultations. All three were
superiority trials that utilized the telephone for consulta-
tions, and only one evaluated physiotherapy. Although a
large equivalence trial showed that telephone-delivered
physiotherapy care was equally clinically effective as usual
care in the UK [59], a diverse sample of participants with
mixed musculoskeletal conditions was recruited and video
consultations were not evaluated. The paucity of literature
evaluating the effectiveness of video consultations for
management of knee OA is a barrier to its implementation
as an alternative method of delivering care by physiothera-
pists. A significant limitation is the absence of data about
its cost-effectiveness.
The Australian Telehealth Society has called for in-
creased research to better understand the economic ben-
efits of telehealth, particularly for patients and the
broader health system, and not just funders of services
[60]. In its National Telehealth Strategy, the Australian
Telehealth Society has also recognized the need to inves-
tigate the impact of telehealth on consumers, arguing
telehealth will not succeed unless consumers can access
it and find value in it [61]. Key actions in this Strategy
include determining consumer attitudes, enablers and
barriers to telehealth and assessment of consumer feed-
back from telehealth trials. Findings from the PEAK
RCT will provide valuable evidence about the clinical ef-
fectiveness and cost-effectiveness of video-conferencing
by physiotherapists for people with knee OA. Results
will inform the development and implementation of tele-
health physiotherapy models and will have relevance to
other chronic musculoskeletal diseases where education,
exercise and physical activity are a cornerstone of man-
agement. Trial findings will be particularly relevant in
light of the COVID-19 pandemic which has prompted
many health services globally to switch from face-to-face
consultations to video-conferencing in order to protect
the health of both patients and staff.
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